Ministry of health in iran is serious about controlling hepatitis B

Hepatitis Monthly

Volumn 7, Issue 1, 2007, Pages 3-5

  Alavian, Seyed Moayed ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LIVER FAILURE; BLOOD TRANSFUSION; CHRONIC HEPATITIS; EDITORIAL; HEALTH; HEALTH CARE; HEPATITIS B; HUMAN; IRAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MORBIDITY; MORTALITY; PREVALENCE; VACCINATION;

EID: 38049104415     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population a viral marker study. Ann Acad Med Singapore 1980; 9: 144-8.
2. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med 2000; 3: 192-201.
3. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg 1993; 96: 277-87.
4. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J 2000; 6: 1114-6.
5. Bagheri Lankarani K, Saberi Froozi M, Nabipoor I, Fattahi F, Sarafrazyazdi M, Malekzadeh R, et al. Reassesment of the role of hepatitis B and C viruses in southern Iran. Iranian J Med Sci 1999; 24: 117-21.
6. Shamszad M, Farzadegan H. Hepatitis B related cirrhosis and hepatocellular carcinoma in Iran. J Irn Med Council1982; 8: 228.
7. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran. J Irn Med Council 1997; 15: 183-200.
8. Toukan A. Control of hepatitis B in the Middle East. In: Rizetto M, et al., editors. Viral hepatitis and liver diseases. Turin: Minerva Medica 1997. P. 678-80.
9. Zali MR, Mohammad K, Noorbala AA, Noorinayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J 2005; 11: 62-7.
10. Alavian SM, Mostajabi P, Malekzadeh R, Azimi K, Vosoogh H, Sarrafi M, et al. Evaluation of Hepatitis B Transmission Risk Factors in Tehran Blood Donors. Govaresh 2004; 9: 169-75.
11. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B Prevalence and Risk Factors in Blood Donors in Ghazvin, IR.Iran. Hep Mon 2005; 5: 117-22.
12. Sali S, Bashtar R, Alavian SM. Risk Factors in Chronic Hepatitis B Infection: A Case-control Study. Hep Mon 2005; 5: 109-15.
13. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res 2006; 36: 265-71.
14. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18: S20-2.